| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 2.62M | -96.86% |
| Operating expense | — | — |
| Net income | -37.69M | -200.65% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OSE.PA returned -49.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -37.7% |
| 1 year | -49.2% |
| 5 years | -73.1% |
| 10 years | -52.4% |
| All-time high | €13.70 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in OSE.PA would be worth today ›No. OSE Immunotherapeutics SA has not paid a dividend in the past 12 months.
OSE Immunotherapeutics SA is part of the Healthcare sector.
OSE Immunotherapeutics SA has a market cap of 75.98M EUR, based on the latest quote.
OSE Immunotherapeutics SA is expected to report earnings around Sep 28, 2026. That date is an estimate and has not been confirmed by the company.
